Xiaoming Meng

Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Mitophagy and Cellular Homeostasis in Kidney Diseases: Mechanisms and Potential Therapeutics.

Mitophagy and Cellular Homeostasis in Kidney Diseases: Mechanisms and Potential Therapeutics.

Journal: International journal of biological sciences

Published: May 27, 2026

Myeloid CD36 deficiency alleviates hepatic fibrosis by promoting adaptive immunity of macrophages.

Myeloid CD36 deficiency alleviates hepatic fibrosis by promoting adaptive immunity of macrophages.

Journal: Hepatology (Baltimore, Md.)

Published: June 11, 2025

ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis.

ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis.

Journal: International journal of biological sciences

Published: May 31, 2025

Emerging epigenetic modifications in renal fibrosis: From mechanisms to treatments.

Emerging epigenetic modifications in renal fibrosis: From mechanisms to treatments.

Journal: Acta pharmaceutica Sinica. B

Published: April 15, 2025

PARylation promotes acute kidney injury via RACK1 dimerization-mediated HIF-1α degradation.

PARylation promotes acute kidney injury via RACK1 dimerization-mediated HIF-1α degradation.

Journal: Acta pharmaceutica Sinica. B

Published: March 14, 2025

C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation.

C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 25, 2024

N 6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis.

N 6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis.

Journal: Acta pharmaceutica Sinica. B

Published: April 01, 2024

Hepatic-derived BMP9 is involved in hepatic fibrosis-induced kidney injury through inhibition of renal VEGFA.

Hepatic-derived BMP9 is involved in hepatic fibrosis-induced kidney injury through inhibition of renal VEGFA.

Journal: Biochemical pharmacology

Published: December 20, 2023

Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Journal: EClinicalMedicine

Published: November 08, 2023

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.

A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 31, 2023

Dissecting the immune discrepancies in mouse liver allograft tolerance and heart/kidney allograft rejection.

Dissecting the immune discrepancies in mouse liver allograft tolerance and heart/kidney allograft rejection.

Journal: Cell proliferation

Published: June 04, 2023

PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation.

PSTPIP2 ameliorates aristolochic acid nephropathy by suppressing interleukin-19-mediated neutrophil extracellular trap formation.

Journal: eLife

Published: May 29, 2023

Showing 1-12 of 62

Last Updated: 09/26/2026